Targeting the cyclin dependent kinase and retinoblastoma axis overcomes standard of care resistance in BRAF V600E -mutant melanoma
针对细胞周期蛋白依赖性激酶和视网膜母细胞瘤轴克服了 BRAF V600E 突变型黑色素瘤的标准治疗耐药性
期刊:Oncotarget
影响因子:
doi:10.18632/oncotarget.23649
Antoneicka L Harris, Samantha E Lee, Louis K Dawson, Laura A Marlow, Brandy H Edenfield, William F Durham, Thomas J Flotte, Michael Thompson, Daniel L Small, Aidan J Synnott, Svetomir N Markovic, John A Copland
